Literature DB >> 3237549

Pituitary pathology in Cushing's disease.

W Saeger1, F Geisler, D K Lüdecke.   

Abstract

Pituitaries of 137 cases with Cushing's disease were microscopically and immunohistologically studied. Many alterations and parameters (sex, age, anamnesis, cortisol plasma levels, tumor size, invasiveness, localization, differentiation of adenomas, immunohistological hormone content, capillarity, recurrences, peritumorous ACTH cell hyperplasia, and Crooke's cells) were analyzed and compared. Whereas most parameters were not correlated, we found some important statistically significant correlations: Undifferentiated adenomas are more frequently invasive than differentiated ones. Invasive adenomas recur more frequently than non-invasive adenomas. Extremely laterally localized adenomas are more often invasive. Larger adenomas are more frequently invasive than micro-adenomas. ACTH cell hyperplasia are more often demonstrable in specimens from total hypophysectomies (confined to our earlier series) than from partial hypophysectomies and adenomectomies. Recurrences of adenomas are more frequent in pituitaries with periadenomous ACTH cell hyperplasia. Very rarely ACTH cell hyperplasia are the only source of ACTH hyperfunction. The more Crooke's cells are demonstrable, the longer the post-operative replacement dose of Cortisol is required. Adenomas in Cushing's disease and adenomas in Nelson's syndrome differ significantly in the following points: Adenomas in Nelson's syndrome are larger and contain more plurinuclear cells. In the ultrastructure, adenomas in Cushing's disease show more cytofilaments. Paraadenomous Crooke's cells are lacking in Nelson's syndrome.

Entities:  

Mesh:

Year:  1988        PMID: 3237549     DOI: 10.1016/S0344-0338(88)80018-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  9 in total

Review 1.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

2.  Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.

Authors:  W A Reuss; W Saeger; D K Lüdecke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases.

Authors:  T Sano; K Kovacs; S L Asa; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Metamorphosis of a non-functioning pituitary adenoma to Cushing's disease.

Authors:  E U Tan; M S Ho; C R Rajasoorya
Journal:  Pituitary       Date:  2000-10       Impact factor: 4.107

Review 5.  Cushing's disease: a surgical view.

Authors:  D K Lüdecke; J Flitsch; U J Knappe; W Saeger
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 6.  [Pituitary gland tumors].

Authors:  W Saeger
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

7.  Failure of Partial Hypophysectomy as Definitive Treatment in Cushing's Disease Owing to Nodular Corticotrope Hyperplasia: Report of Four Cases.

Authors:  Luiz R. Salgado; Berenice B. Mendonca; Jayme Goldman; Mauro Semer; Mirta Knoepfelmacher; Ana M. Tsanaclis; Bernardo L. Wajchenberg; Bernardo Liberman
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

Review 8.  Prevalence and clinical characteristics of Crooke's cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review.

Authors:  Dimin Zhu; Zongming Wang; Tian Tian; Xinyi Wu; Dongsheng He; Yonghong Zhu; Dawei Liu; Haijun Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-19       Impact factor: 6.055

9.  Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs.

Authors:  Jennifer M Eschbacher; Stephen W Coons
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.